Sponsors

Transfusion partnership continues in Ireland

Beckman Coulter has announced that it will be continuing its partnership with the Irish Blood Transfusion Service, moving the collaboration forwards with the installation of Beckman Coulter’s newest automated microplate system.

The Irish Blood Transfusion Service (IBTS) is the statutory entity responsible for national blood supply in Ireland. Beckman Coulter’s newly released donor testing analysers, the PK7400s, will be installed in the National Blood Centre in Dublin – a centre that welcomes 150,000 donors every year. The partnership, which has been in place for over a decade, will, with new equipment, run for an initial period of five years, with a two-year extension option available.

The PK7400 Automated Microplate System delivers the industry’s highest throughput on the market at 300 samples per hour, providing an easy-to-use software interface, streamlined maintenance, and remote connectivity to simplify laboratory workflow, maximise productivity and strengthen confidence in operational performance and results reporting. The PK7400 continues to provide total confidence in the primary blood group screening process to ensure patients receive their blood safely.

Rob Young (Ireland and UK General Manager for Beckman Coulter) said: “We are proud to continue to support the IBTS with Beckman Coulter's three decades of demonstrated market leadership in blood bank donor centres worldwide. Delivering peace of mind and analytical confidence, the PK7400s will be used for every blood donation in Ireland, to assign an ABO, RhD, extended Rh phenotype, antibody screen and high-titre A/B result.”

www.beckmancoulter.com/en/products/blood-banking

 

Latest Issues

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025